Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
curasan
Kleinostheim, Bavaria, Germanycurasan.com ↗
- Ownership
- Private
- Employees
- ~17
- Development stage
- Other
01
Overview
curasan has over three decades of experience developing commercialized biomaterials for dental, orthopedic, spine, trauma, and wound healing applications. Their flagship products—CERASORB®, OSBONE®, OSGIDE®, ALLOSORB®, CERACELL®—are used by surgeons globally for bone/tissue regeneration. The company’s solutions are available in several European markets with a legacy of clinical use. No specific recent clinical trial results were found.
- Therapeutic areas
- OtherRheumatology
- Modalities
- Biomaterials (synthetic and allograft)Collagen sponges/membranesBone graft substitutes
- Industry
- Surgical Medical Devices
Beyond the preview
Go deeper on curasan.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on curasan.